NAD+
Nicotinamide Adenine Dinucleotide / NAD
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme present in every living cell, functioning as an essential electron carrier in mitochondrial energy production and as a substrate for sirtuins, PARPs, and CD38 enzymes involved in DNA repair and cellular signaling. Declining NAD+ levels are strongly associated with aging and metabolic dysfunction, making NAD+ repletion a major focus of longevity research. It is administered via IV infusion, subcutaneous injection, or oral precursors (NMN, NR) in anti-aging and neurological research protocols.
Mécanisme d'action
Essential coenzyme present in all living cells. Central to cellular energy metabolism (glycolysis, TCA cycle, oxidative phosphorylation), DNA repair (PARP enzymes), epigenetic regulation (sirtuins), and calcium signaling. Levels decline ~50% between ages 40-60.
Protocoles de recherche
Pour des fins de recherche uniquement. Pas de conseil médical.
Research protocols use 250-750mg via IV infusion over 2-4 hours. Subcutaneous protocols use 50-100mg daily. Intranasal formulations under investigation. IV sessions typically weekly for 4-8 weeks, then monthly maintenance.
Notes de recherche
Clinical Research Status
NAD+ IV therapy is actively studied in clinical trials for conditions including chronic fatigue, neurodegenerative diseases, substance use disorders, and age-related metabolic decline. The precursors NMN and NR have multiple ongoing Phase I/II trials examining bioavailability, safety, and effects on aging biomarkers. While IV NAD+ clinics have proliferated globally, FDA-approved therapeutic indications remain limited to experimental and integrative medicine settings.
Key Published Findings
Research has demonstrated that NAD+ levels decline by approximately 50% between ages 40 and 60, correlating with mitochondrial dysfunction and increased disease susceptibility. Studies in animal models show that NAD+ repletion restores mitochondrial function, improves insulin sensitivity, and extends healthspan markers. Human trials with NR supplementation have confirmed dose-dependent increases in blood NAD+ levels with good tolerability, though functional clinical endpoints are still being validated.
Safety Profile
IV NAD+ infusions are generally well-tolerated but commonly produce transient side effects including chest tightness, nausea, abdominal cramping, and flushing during infusion, which are managed by slowing the drip rate. Oral precursors NMN and NR show excellent safety profiles in clinical doses of 250-1000mg daily with minimal adverse events reported. Theoretical concerns exist about long-term high-dose NAD+ supplementation potentially fueling growth of existing cancers, though clinical evidence for this remains inconclusive.
Drug Interactions & Contraindications
NAD+ may interact with blood pressure medications due to its vasodilatory effects during IV administration. Caution is advised with concurrent use of chemotherapeutic agents, as NAD+-dependent PARP inhibitors may have altered efficacy. Patients with active malignancies should consult their oncologist before beginning NAD+ therapy given the theoretical role of NAD+ in supporting cellular proliferation.
Comparison to Related Compounds
NMN (nicotinamide mononucleotide) is a direct NAD+ precursor requiring one enzymatic step for conversion, offering potentially faster NAD+ elevation than NR. NR (nicotinamide riboside) has more published human clinical trial data and established commercial availability as a supplement (TruNiagen, Elysium). Direct IV NAD+ bypasses the need for enzymatic conversion entirely but requires clinical administration and produces more acute side effects than oral precursors.
Community Observations
Users of IV NAD+ commonly report initial sessions being uncomfortable due to nausea and chest tightness, with subsequent sessions becoming more tolerable as the body adapts. Many practitioners administer loading protocols of 500-1000mg IV daily for 3-5 days followed by monthly maintenance infusions. The biohacking community frequently combines NAD+ protocols with resveratrol and fasting to maximize sirtuin activation and perceived anti-aging benefits.
Moitié de vie
~45 minutes (IV)
Réconstitution
Sterile saline for IV; bacteriostatic water for SubQ
Conservation
Lyophilisé
Refrigerate 2-8C. Protect from light.
Réconstitué
Use within 24 hours of preparation (IV). SubQ: within 7 days.
Statut légal aux États-Unis
Autres noms connus
Questions fréquentes
Qu'est-ce que NAD+ ?
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme present in every living cell, functioning as an essential electron carrier in mitochondrial energy production and as a substrate for sirtuins, PARPs, and CD38 enzymes involved in DNA repair and cellular signaling. Declining NAD+ levels are strongly associated with aging and metabolic dysfunction, making NAD+ repletion a major focus of longevity research. It is administered via IV infusion, subcutaneous injection, or oral precursors (NMN, NR) in anti-aging and neurological research protocols.
Comment agit NAD+ ?
Essential coenzyme present in all living cells. Central to cellular energy metabolism (glycolysis, TCA cycle, oxidative phosphorylation), DNA repair (PARP enzymes), epigenetic regulation (sirtuins), and calcium signaling. Levels decline ~50% between ages 40-60.
Quel est le statut réglementaire de NAD+ aux États-Unis ?
Supplement (not FDA-regulated as drug)
Quelle est la demi-vie de NAD+ ?
~45 minutes (IV)
Sous quels autres noms NAD+ est-il connu ?
Nicotinamide Adenine Dinucleotide, NAD
Peptide Contacts fournit des résumés basés sur la recherche à des fins d’information uniquement. Nous ne hébergeons, n’épandons ni ne recommandons les documents des fournisseurs. Toutes les certificats d'analyse, certificats GMP et communications du fournisseur doivent être demandés et vérifiés directement par l'acheteur. Rien sur cette plateforme ne constitue un avis juridique, médical ou professionnel. Les utilisateurs sont entièrement responsables de la vérification des informations du fournisseur et de l’assurance de la conformité avec toutes les lois locales, d'état et fédérales applicables avant l'achat de tout produit chimique de recherche. L'utilisation de cette plateforme constitue l'acceptation pleine et entière de la responsabilité personnelle.
Lire la déclaration complète